Locoregional therapy for cervical lesions
As mentioned previously, none of the drug-based locoregional therapies so far developed for HPV infection are licensed for the management of cervical dysplasia. There have, however, been some promising results from trials of locoregional therapy for cervical lesions. We will now discuss in greater detail some of these studies involving 5-Flourouracil, Cidofovir and more recently, Lopimune, including some of the advantages, limitations, and the potential for clinical use of the various therapies.